Journal of Gastrointestinal Surgery

, Volume 16, Issue 7, pp 1296–1302

Body Mass Index and Survival in Esophageal Adenocarcinoma Treated with Chemoradiotherapy Followed by Esophagectomy

  • Ravi Shridhar
  • Thomas Hayman
  • Sarah E. Hoffe
  • Jill Weber
  • Khaldoun Almhanna
  • Michael Chuong
  • Richard C. Karl
  • Kenneth L. Meredith
Original Article



Body mass index (BMI) has been linked with inferior outcomes in gastrointestinal malignancies. The purpose of this study is to evaluate the effect of BMI on survival in patients with esophageal adenocarcinoma.


Medical records were analyzed for patients who underwent esophagectomy after neoadjuvant chemoradiotherapy (nCRT) for adenocarcinoma from 2000 to the present. Patients were grouped into BMI ≤25, >25–30, >30–35, and BMI >35. Overall survival (OS) and disease-free survival (DFS) were analyzed using the Kaplan–Meier method. Multivariate analysis (MVA) was performed using Cox proportional hazard regression model.


We identified 303 patients for the analysis. The only difference in patient characteristics between groups was gender. We found no difference in OS and DFS associated with BMI (p = 0.3297 for OS; p = 0.5950 for DFS). There were no differences in postoperative complications or mortality between BMI groups. MVA revealed that higher stage and less than a complete response to nCRT were prognostic for worse OS and DFS, while age, gender, type of surgery, year of diagnosis, and BMI were not prognostic.


BMI was neither associated with surgical complications nor survival in patients with esophageal adenocarcinoma treated with nCRT. BMI should not be considered a contraindication to surgical resection after nCRT.


Body mass index Esophageal adenocarcinoma Esophagectomy Neoadjuvant chemoradiotherapy 


  1. 1.
    Cancer Statistics, in Clinical Cancer Advances 20092009, American Society of Clinical Oncology: Alexandria, VA.Google Scholar
  2. 2.
    Lambert, R. and P. Hainaut, Esophageal cancer: cases and causes (part I). Endoscopy, 2007. 39(6): p. 550-5.PubMedCrossRefGoogle Scholar
  3. 3.
    Blot, W.J. and J.K. McLaughlin, The changing epidemiology of esophageal cancer. Semin Oncol, 1999. 26(5 Suppl 15): p. 2-8.PubMedGoogle Scholar
  4. 4.
    Brown, L.M., S.S. Devesa, and W.H. Chow, Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst, 2008. 100(16): p. 1184-7.PubMedCrossRefGoogle Scholar
  5. 5.
    Renehan, A.G., et al., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 2008. 371(9612): p. 569-78.PubMedCrossRefGoogle Scholar
  6. 6.
    Chak, A., et al., Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction. Am J Gastroenterol, 2009. 104(8): p. 1913-21.PubMedCrossRefGoogle Scholar
  7. 7.
    Carmichael, A.R., Obesity and prognosis of breast cancer. Obes Rev, 2006. 7(4): p. 333-40.PubMedCrossRefGoogle Scholar
  8. 8.
    Chlebowski, R.T., E. Aiello, and A. McTiernan, Weight loss in breast cancer patient management. J Clin Oncol, 2002. 20(4): p. 1128-43.PubMedCrossRefGoogle Scholar
  9. 9.
    Dignam, J.J., et al., Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst, 2006. 98(22): p. 1647-54.PubMedCrossRefGoogle Scholar
  10. 10.
    Li, D., et al., Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA, 2009. 301(24): p. 2553-62.PubMedCrossRefGoogle Scholar
  11. 11.
    Chow, W.H., et al., Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst, 1998. 90(2): p. 150-5.PubMedCrossRefGoogle Scholar
  12. 12.
    El-Serag, H.B., et al., Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol, 2005. 100(10): p. 2151-6.PubMedCrossRefGoogle Scholar
  13. 13.
    Lagergren, J., R. Bergstrom, and O. Nyren, Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med, 1999. 130(11): p. 883-90.PubMedGoogle Scholar
  14. 14.
    Shaheen, N. and D.F. Ransohoff, Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. Jama, 2002. 287(15): p. 1972-81.PubMedCrossRefGoogle Scholar
  15. 15.
    Murray, L., et al., Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter Project. Int J Epidemiol, 2003. 32(4): p. 645-50.PubMedCrossRefGoogle Scholar
  16. 16.
    Nilsson, M., et al., Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. Jama, 2003. 290(1): p. 66-72.PubMedCrossRefGoogle Scholar
  17. 17.
    Calle, E.E., et al., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med, 2003. 348(17): p. 1625-38.PubMedCrossRefGoogle Scholar
  18. 18.
    Enzinger, P.C. and R.J. Mayer, Esophageal cancer. N Engl J Med, 2003. 349(23): p. 2241-52.PubMedCrossRefGoogle Scholar
  19. 19.
    Vaughan, T.L., et al., Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev, 1995. 4(2): p. 85-92.PubMedGoogle Scholar
  20. 20.
    Moon, H.G., et al., Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol, 2008. 15(7): p. 1918-22.PubMedCrossRefGoogle Scholar
  21. 21.
    Stewart, S.T., D.M. Cutler, and A.B. Rosen, Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med, 2009. 361(23): p. 2252-60.PubMedCrossRefGoogle Scholar
  22. 22.
    Dindo, D., et al., Obesity in general elective surgery. Lancet, 2003. 361(9374): p. 2032-5.PubMedCrossRefGoogle Scholar
  23. 23.
    Melis, M., et al., An elevated body mass index does not reduce survival after esophagectomy for cancer. Annals of surgical oncology, 2011. 18(3): p. 824-31.PubMedCrossRefGoogle Scholar
  24. 24.
    Grotenhuis, B.A., et al., Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer. World J Surg, 2010.Google Scholar
  25. 25.
    Kilic, A., et al., Impact of obesity on perioperative outcomes of minimally invasive esophagectomy. Ann Thorac Surg, 2009. 87(2): p. 412-5.PubMedCrossRefGoogle Scholar
  26. 26.
    Healy, L.A., et al., Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg, 2007. 134(5): p. 1284-91.PubMedCrossRefGoogle Scholar
  27. 27.
    Morgan, M.A., et al., Prognostic significance of body mass indices for patients undergoing esophagectomy for cancer. Dis Esophagus, 2007. 20(1): p. 29-35.PubMedCrossRefGoogle Scholar
  28. 28.
    Rodriguez, C., et al., Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev, 2001. 10(4): p. 345-53.PubMedGoogle Scholar
  29. 29.
    Rodriguez, C., et al., Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women. Am J Epidemiol, 2001. 153(2): p. 145-52.PubMedCrossRefGoogle Scholar
  30. 30.
    McRackan, T.R., et al., Effect of body mass index on chemoradiation outcomes in head and neck cancer. Laryngoscope, 2008. 118(7): p. 1180-5.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2012

Authors and Affiliations

  • Ravi Shridhar
    • 1
    • 4
  • Thomas Hayman
    • 2
  • Sarah E. Hoffe
    • 1
    • 4
  • Jill Weber
    • 3
    • 4
  • Khaldoun Almhanna
    • 3
    • 4
  • Michael Chuong
    • 1
  • Richard C. Karl
    • 3
    • 4
  • Kenneth L. Meredith
    • 3
    • 4
  1. 1.Department of Radiation OncologyH. Lee Moffitt Cancer CenterTampaUSA
  2. 2.School of MedicineUniversity of South FloridaTampaUSA
  3. 3.Gastrointestinal Tumor ProgramH. Lee Moffitt Cancer CenterTampaUSA
  4. 4.H. Lee Moffitt Cancer CenterTampaUSA

Personalised recommendations